⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7672116 | 0.72 | — | — | |
| SCHEMBL7671825 | 0.69 | — | — | |
| SCHEMBL35239 | 0.67 | ALDH1A1 (0.42) | — | |
| SCHEMBL24856 | 0.67 | — | — | |
| SCHEMBL8728533 | 0.65 | — | — | |
| SCHEMBL7675766 | 0.65 | — | — | |
| SCHEMBL7672951 | 0.65 | — | — | |
| SCHEMBL20101 | 0.64 | — | — | |
| SCHEMBL6577079 | 0.64 | ALDH1A1 (0.40) | — | |
| Water SCHEMBL20597605 | 0.64 | ALDH1A1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| EP-3045443-B1 | METHOD FOR PRODUCING -CYCLOLAVANDULAL AND DERIVATIVE OF SAME | SHINETSU CHEMICAL CO (JP) | 2018-05-02 | — | — | EP | disclosed |
| US-9708241-B2 | Methods for producing β-cyclolavandulal and derivative of same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9670130-B2 | — | — | 2017-06-06 | — | — | US | disclosed |
| US-20160221924-A1 | METHODS FOR PRODUCING BETA-CYCLOLAVANDULAL AND DERIVATIVE OF SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-04 | — | — | US | disclosed |
| EP-3045443-A1 | METHOD FOR PRODUCING -CYCLOLAVANDULAL AND DERIVATIVE OF SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2016-07-20 | — | — | EP | disclosed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | disclosed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | disclosed |
| EP-0668259-A1 | A method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1995-08-23 | — | — | EP | disclosed |
| US-5434302-A | Method for the preparation of optically active 2-aryl alkyl aldehydes and formation of 2-aryl-alkanoic acids therefrom | PARADIES H HENRICH (DE) | 1995-07-18 | — | — | US | disclosed |
| EP-0193853-B1 | 3(2H)PYRIDAZINONE, PROCESS FOR ITS PREPARATION AND ANTI-ALLERGIC AGENT CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1990-09-12 | — | — | EP | disclosed |
| US-4783462-A | 3(2H)pyridazinone, and anti-allergic agent containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1988-11-08 | — | — | US | disclosed |
| US-4722958-A | POLYMERIZING IN TERT-BUTANOL MIXTURE OF (METH)ACRYLAMIDE, (METH) ACRYLIC ACID, COPOLYMERIZABLE MONOMER AND CROSSLINKING AGENT | CASSELLA AKTIENGESELLSCHAFT (DE) | 1988-02-02 | — | — | US | disclosed |
| EP-0193853-A2 | 3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-09-10 | — | — | EP | disclosed |
| EP-0153678-A1 | Cinnamic acid derivatives, processes for the preparation thereof and pharmaceutical compositions | Tanabe Seiyaku Co., Ltd. (JP) | 1985-09-04 | — | — | EP | disclosed |